Skip to main content
. 2017 Jul 26;8(59):99414–99428. doi: 10.18632/oncotarget.19562

Table 3. AQP1 expression and clinicopathological variables of astrocytoma.

Pathological features Cases AQP1 score, n (%) rs P valuea
0 1-4 5-9
Ageb 160 0.733
Tumor sizec 160 0.587
Gender −0.122 0.123
 Male 95 5 (5.3) 21(22.1) 69 (72.6)
 Female 65 3 (4.6) 23 (35.4) 39 (60.0)
Histological grade 0.163 0.039
 Grade II 47 8 (17.0) 11 (23.4) 28 (59.6)
 Grade III 48 0 (0.0) 16 (33.3) 32 (66.7)
 Grade IV 65 0 (0.0) 17 (26.2) 48 (73.8)
Peritumoral edema −0.006 0.943
 Weak 35 3 (8.6) 9 (25.7) 23 (65.7)
 Moderate 78 4 (5.1) 19 (24.4) 55 (70.5)
 Strong 47 1 (2.1) 16 (34.0) 30 (63.8)
Location −0.003 0.972
 Frontal 54 3 (5.6) 16 (29.6) 35 (64.8)
 Temporal 47 1 (2.1) 11 (23.4) 35 (74.5)
 Parietal 14 1 (7.1) 5 (35.7) 8 (57.1)
 Occipital 7 2 (28.6) 0 (0.0) 5 (71.4)
 Cerebrum 4 0 (0.0) 1 (25.0) 3 (75.0)
 Callosum/ventricle/thalamus 12 1 (8.3) 3 (25.0) 8 (66.7)
 More than one lobe 22 0 (0.0) 8 (36.4) 14 (63.6)

aP values were calculated by Spearman’s Rank-Correlation test.

bAge: 49 (9–80) years, F = 0.311, P = 0.733 (ANOVA test).

cTumor size: (4.7 ± 1.6) cm, F = 0.534, P = 0.587 (ANOVA test).